Inventor · disambiguated record
Amir Tamiz
Also filed as: TAMIZ AMIR · TAMIZ AMIR P
17 granted patents·12 pending applications·101 citations·filing 1999–2021
93Inventor score
Top patents by PatentIndex Score
29 records- 0192US6586405B2Non-covalent inhibitors of urokinase and blood vessel formationCORVAS INT INC·Filed 2000·Granted Jul 1, 2003·39 cites·90 claims
- 0291US8299017B2Use of tight junction antagonists to treat inflammatory bowl diseasePATERSON BLAKE·Filed 2010·Granted Oct 30, 2012·8 cites·14 claims
- 0390US8796203B2Use of tight junction antagonists to treat inflammatory bowel diseasePATERSON BLAKE·Filed 2012·Granted Aug 5, 2014·6 cites·14 claims
- 0487US8785374B2Inhibitors of mammalian tight junction openingTAMIZ AMIR·Filed 2008·Granted Jul 22, 2014·9 cites·14 claims
- 0584US11149063B2Peptide inhibitors of tight junction permeabilityALBA THERAPEUTICS CORP·Filed 2019·Granted Oct 19, 2021·2 cites·9 claims
- 0684US8198233B2Synthetic peptides that enhance tight junction permeabilityTAMIZ AMIR·Filed 2008·Granted Jun 12, 2012·6 cites·6 claims
- 0783US9056923B2Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseasesPOPEL ALEKSANDER S·Filed 2011·Granted Jun 16, 2015·3 cites·5 claims
- 0882US8557763B2Synthetic peptides that enhance tight junction permeabilityTAMIZ AMIR·Filed 2012·Granted Oct 15, 2013·3 cites·6 claims
- 0979US8957032B2Inhibition of gliadin peptidesALKAN SEFIK·Filed 2009·Granted Feb 17, 2015·6 cites·5 claims
- 1078US10526372B2Inhibition of gliadin peptidesALBA THERAPEUTICS CORP·Filed 2018·Granted Jan 7, 2020·2 cites·14 claims
- 1176US10106597B2Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseasesUNIV JOHNS HOPKINS·Filed 2016·Granted Oct 23, 2018·1 cites·17 claims
- 1273US2022009965A1Peptide inhibitors of tight junction permeabilityALBA THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 1372US11155603B2Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseasesUNIV JOHNS HOPKINS·Filed 2020·Granted Oct 26, 2021·0 cites·11 claims
- 1471US7019019B2Matriptase inhibitors and methods of useDENDREON CORP·Filed 2003·Granted Mar 28, 2006·6 cites·42 claims
- 1571US2009069247A1Use of tight junction antagonists to treat inflammatory bowel diseasePATERSON BLAKE·Filed 2007·Application pending·0 cites
- 1670US2014296165A1Use of tight junction antagonists to treat inflammatory bowel diseaseALBA THERAPEUTICS CORP·Filed 2014·Application pending·0 cites
- 1766US10774131B2Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseasesUNIV JOHNS HOPKINS·Filed 2018·Granted Sep 15, 2020·0 cites·18 claims
- 1863US6605621B1Monomeric and dimeric heterocycles, and therapeutic uses thereofUNIV GEORGETOWN·Filed 2002·Granted Aug 12, 2003·1 cites·3 claims
- 1962US2016151449A1Use of tight junction antagonists to treat inflammatory bowel diseaseALBA THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 2060US2014296130A1Novel inhibitors of mammalian tight junction openingALBA THERAPEUTICS CORP·Filed 2014·Application pending·0 cites
- 2158US2018133281A1Novel inhibitors of mammalian tight junction openingALBA THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 2256US2015307592A1Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseasesUNIV JOHNS HOPKINS·Filed 2015·Application pending·0 cites
- 2355US2014171377A1Novel peptides that enhance tight junction permeabilityALBA THERAPEUTICS CORP·Filed 2013·Application pending·0 cites
- 2454US2017096451A1Inhibition of gliadin peptidesALBA THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 2553US6440996B1Monomeric and dimeric heterocycles, and therapeutic uses thereofUNIV GEORGETOWN·Filed 1999·Granted Aug 27, 2002·9 cites·34 claims
- 2653US2016228488A1Novel inhibitors of mammalian tight junction openingALBA THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 2750US2015203537A1Inhibition of gliadin peptidesALBA THERAPEUTICS CORP·Filed 2015·Application pending·0 cites
- 2839US7262211B2Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formationDENDREON CORP·Filed 2002·Granted Aug 28, 2007·0 cites·19 claims
- 2937US2012027720A1Peptide conjugatesTAMIZ AMIR·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amir Tamiz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →